No influence of nevirapine on vitamin D deficiency in HIV-infected patients

AIDS Research and Human Retroviruses

Volumn 25, Issue 8, 2009, Pages 849-850

  Lattuada, Emanuela ^a   Lanzafame, Massimiliano ^a   Zoppini, Giacomo ^b   Concia, Ercole ^a   Vento, Sandro ^c  

^a Infectious Diseases Unit   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Annunziata Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; NEVIRAPINE;

BONE DENSITY; CD4 LYMPHOCYTE COUNT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SUN EXPOSURE; VIRUS LOAD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

ANTI-HIV AGENTS; HIV; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; NEVIRAPINE; VITAMIN D DEFICIENCY;

EID: 70349199471     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0063     Document Type: Letter

References (2)

1. Van Den Bout-Van Den Beukel CJP, Fievez L, Michels M, et al.: Vitamin D Deficiency among HIV type 1 infected individuals in the Netherlands: Effect of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;11:1375-1382.
2. Rodriguez M, Daniels B, Gunawardene S, and Robbins GK: High frequency of vitamin D Deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009;1: 9-14.